Jean-Jacques Bienaim
2008
In 2008, Jean-Jacques Bienaim earned a total compensation of $10.5M as Chief Executive Officer at BioMarin Pharmaceutical.
Compensation breakdown
| Non-Equity Incentive Plan | $769,500 |
|---|---|
| Option Awards | $7,891,080 |
| Salary | $673,439 |
| Stock Awards | $1,157,700 |
| Other | $31,875 |
| Total | $10,523,594 |
Bienaim received $7.9M in option awards, accounting for 75% of the total pay in 2008.
Bienaim also received $769.5K in non-equity incentive plan, $673.4K in salary, $1.2M in stock awards and $31.9K in other compensation.
Rankings
In 2008, Jean-Jacques Bienaim's compensation ranked 250th out of 9,135 executives tracked by ExecPay. In other words, Bienaim earned more than 97.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 250 out of 9,135 | 97th |
Division Manufacturing | 69 out of 3,436 | 98th |
Major group Chemicals And Allied Products | 12 out of 815 | 99th |
Industry group Drugs | 10 out of 597 | 98th |
Industry Pharmaceutical Preparations | 8 out of 408 | 98th |
Source: SEC filing on March 29, 2011.
Bienaim's colleagues
We found three more compensation records of executives who worked with Jean-Jacques Bienaim at BioMarin Pharmaceutical in 2008.
News
BioMarin Pharmaceutical CEO Jean-Jacques Bienaim's 2021 pay rises 1% to $18M
April 12, 2022
BioMarin Pharmaceutical CEO Jean-Jacques Bienaim's 2020 pay slips 2% to $18M
April 13, 2021
BioMarin Pharmaceutical CEO Jean-Jacques Bienaim's 2019 pay rises 18% to $18M
April 14, 2020
BioMarin Pharmaceutical CEO Jean-Jacques Bienaim's 2018 pay slips 2% to $16M
April 23, 2019